Displaying 161–170 of 871 results
Sep 15, 2022
RD Fund Participates in a €75 Million Series B for SparingVision
Proceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
Sep 13, 2022
Foundation Fighting Blindness Makes Key Appointments to Leadership Team
Several executives promoted to continue the advancement of the Foundation’s notable research and philanthropic efforts.
Sep 12, 2022
Youngest U.S. Blind Golfer Heading to the 2022 Vision Cup
Tyler Cashman is one of six U.S. team members that have been selected to participate in the upcoming 2022 Vision Cup, an international golf competition for the blind hosted by the United States Blind Golf Association (USBGA), taking place on September 19-22, 2022.
Sep 8, 2022
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
The company plans to seek FDA approval for the emerging therapy in first quarter of 2023
Aug 30, 2022
Foundation Insights Forum – August 12, 2022
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on August 12, 2022.
Aug 25, 2022
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
The company’s drug is designed to reduce accumulation of toxins that cause vision loss.
Aug 15, 2022
Decades of Dedication Fighting for His Family and Himself
Dan Day is one of over ten people in his family, spanning six generations, affected with retinitis pigmentosa (RP). So to “get off the sidelines and join the fight” for himself and his family, Dan has dedicated over 25 years of service to the Foundation Fighting Blindness.
Aug 11, 2022
ProQR Seeking to Partner Ophthalmic Programs
The company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2022 (July 1, 2021–June 30, 2022)
Aug 10, 2022
Foundation Commits More Than $15 Million to 23 Promising Research Projects for Eradicating Retinal Diseases
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners